Literature DB >> 15075519

Reduction of mitochondrial DNA content and respiratory chain activity occurs in adipocytes within 6-12 months of commencing nucleoside reverse transcriptase inhibitor therapy.

Emma Hammond, David Nolan, Ian James, Cecily Metcalf, Simon Mallal.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15075519     DOI： 10.1097/00002030-200403260-00015

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  11 in total

1.  Mitochondrial oxidative phosphorylation protein levels in peripheral blood mononuclear cells correlate with levels in subcutaneous adipose tissue within samples differing by HIV and lipoatrophy status.

Authors:  Cecilia M Shikuma; Mariana Gerschenson; Dominic Chow; Daniel E Libutti; John H Willis; James Murray; Roderick A Capaldi; Michael Marusich
Journal:  AIDS Res Hum Retroviruses       Date:  2008-10       Impact factor: 2.205

2.  Management of dyslipidemia in HIV-infected patients.

Authors:  Carlos D Malvestutto; Judith A Aberg
Journal:  Clin Lipidol       Date:  2011-08

Review 3.  Adipose Tissue in HIV Infection.

Authors:  John R Koethe
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

Review 4.  Cardiovascular complications in HIV management: past, present, and future.

Authors:  Judith A Aberg
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

5.  Mitochondrial DNA content, an inaccurate biomarker of mitochondrial alteration in human immunodeficiency virus-related lipodystrophy.

Authors:  Min Ji Kim; Claude Jardel; Cyrille Barthélémy; Véronique Jan; Jean Philippe Bastard; Sandrine Fillaut-Chapin; Sydney Houry; Jacqueline Capeau; Anne Lombès
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

6.  Mitochondrial DNA depletion and respiratory chain activity in primary human subcutaneous adipocytes treated with nucleoside analogue reverse transcriptase inhibitors.

Authors:  Metodi V Stankov; Thomas Lücke; Anibh M Das; Reinhold E Schmidt; Georg M N Behrens
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

7.  Is oxygen a key factor in the lipodystrophy phenotype?

Authors:  Christel Gentil; Sébastien Le Jan; Josette Philippe; Jacques Leibowitch; Pierre Sonigo; Stéphane Germain; France Piétri-Rouxel
Journal:  Lipids Health Dis       Date:  2006-10-18       Impact factor: 3.876

8.  Elevated serum fibroblast growth factor 21 levels correlate with immune recovery but not mitochondrial dysfunction in HIV infection.

Authors:  Brendan Ai Payne; David Ashley Price; Patrick F Chinnery
Journal:  AIDS Res Ther       Date:  2013-11-19       Impact factor: 2.250

9.  The effects of Thiazolidinediones on metabolic complications and Lipodystrophy in HIV-infected patients.

Authors:  Jussi Sutinen
Journal:  PPAR Res       Date:  2008-12-01       Impact factor: 4.964

Review 10.  Prevalence, Risk Factors, and Pathophysiology of Dysglycemia among People Living with HIV in Sub-Saharan Africa.

Authors:  Benson Njuguna; Jepchirchir Kiplagat; Gerald S Bloomfield; Sonak D Pastakia; Rajesh Vedanthan; John R Koethe
Journal:  J Diabetes Res       Date:  2018-05-23       Impact factor: 4.011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.